
Browsing restrictions can be lifted for a fee.
Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. It operates through Manufacturing, Hospital Services, and Distribution segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients' apparels, disposable surgical masks, boot covers and surgical gowns, underpads, adult diapers, crochet blankets, bed linens, and medical bandages. The Hospital Services segment provides laundry and leasing services, including hospital linen rental and laundry, management of hospital laundry facilities, hospital automation, and other non-core hospital functions for hospitals in Taiwan and the Philippines. The Distribution segment markets Medtecs-branded medical consumables to hospitals, pharmacies, and other end users in the Asia Pacific. This segment also supplies other branded medical supplies and equipment comprising wheel chairs, syringes, nebulizers, and blood pressure monitors. Medtecs International Corporation Limited also manufactures, leases, trades in, and sells woven and knitted fabrics, and other made-up articles of textile products; trades in hospital textiles and garments, pillow cases, bed sheets, gowns, and other apparel products; and provides garters and other garment products. It also engages in the subleasing activities; and manufacture and supply personal protective equipment. The company was founded in 1989 and is headquartered in Taipei, Taiwan.
No related data records
9103
美德醫療-DR
-5.70%
(-0.06)
The most recent financial report for 美德醫療-DR (9103) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 9103's short-term business performance and financial health. For the latest updates on 9103's earnings releases, visit this page regularly.
At the end of the period, 美德醫療-DR (9103) held Total Cash and Cash Equivalents of 378.53M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 美德醫療-DR (9103) did not achieve the “three margins increasing” benchmark, with a gross margin of 20.54%%, operating margin of -0.44%%, and net margin of 0.49%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 9103's profit trajectory and future growth potential.